BioNTech SE (BNTX)

113.08 +1.74 (+1.56%) USD  |  NASDAQ  |  Dec 20, 16:00
114.20 +1.12 (+0.99%) After-Hours: 20:00
More

BioNTech Max Drawdown (5Y): 82.24% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for BNTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Edap TMS SA 81.10%
Pfizer Inc 54.78%
Trinity Biotech PLC 96.74%
Akari Therapeutics PLC 98.67%
Moderna Inc 92.39%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) 35.12
Beta (5Y) 0.2165
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 76.18%
Historical Sharpe Ratio (5Y) 0.4989
Historical Sortino (5Y) 1.262
Monthly Value at Risk (VaR) 5% (5Y Lookback) 23.94%